Highlights Current Board’s Empty Promises, Failure to Deliver Value for Shareholders, and Certain Directors’ Concerning Patterns of Reckless, Unethical and Illegal Actions to Retain Control of Sinovac ...
It is time to act. Your vote at the upcoming Special Meeting of Shareholders will shape SINOVAC’s future. SAIF has called this Special Meeting to reconstitute a remnant of the Former Board that the UK ...
Clears another legal hurdle for distribution of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board to be paid on or about July 7, 2025 On June 24, ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results